lesinurad int
lesinurad int Basic information
- Product Name:
- lesinurad int
- Synonyms:
-
- lesinurad int
- Lesinurad INT4
- 2-[[4- (4-cyclopropylnaphthalen-1-yl) -4H-1,2,4-triazol-3-yl] thio] methyl acetate
- Methyl 2-[[4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]acetate
- Acetic acid, 2-[[4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-, methyl ester
- Methyl 2-[[4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]acetate(for Lesinurad)
- 2-[[4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-, methyl ester
- 4-triazol-3-yl]thio]acetate
- CAS:
- 1533519-85-5
- MF:
- C18H17N3O2S
- MW:
- 339.41
- Mol File:
- 1533519-85-5.mol
lesinurad int Chemical Properties
- Boiling point:
- 546.4±60.0 °C(Predicted)
- Density
- 1.38±0.1 g/cm3(Predicted)
- storage temp.
- Sealed in dry,Store in freezer, under -20°C
- pka
- 0.56±0.10(Predicted)
lesinurad int Usage And Synthesis
Synthesis
1533519-84-4
96-32-2
1533519-85-5
In a 100 mL three-necked round-bottomed flask equipped with a magnetic stirrer and thermometer, 25 mL of N,N-dimethylformamide (DMF) and intermediate (III) (2.67 g, 1-cyclopropyl-4-isothiocyanonaphthalene) were added. After stirring at room temperature until complete dissolution, potassium carbonate (1.45 g) and methyl bromoacetate (1.61 g) were added sequentially. The reaction temperature was controlled at 25°C. After the slow addition, the reaction was continued with stirring for 3 hours. Upon completion of the reaction, 50 mL of water was added to the reaction mixture for dilution, followed by extraction with ethyl acetate (50 mL × 3). The organic phases were combined and the ethyl acetate was removed by concentration using a rotary evaporator. To the concentrated residue, 50 mL of methanol was added and heated to reflux to dissolve the crystals, followed by slow cooling to room temperature for recrystallization. The crystals were collected by filtration and washed with a small amount of cold methanol and dried under vacuum to give 3.22 g of Intermediate (IV) (methyl 2-((4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetate) in 99.5% yield.
References
[1] Patent: CN105906576, 2016, A. Location in patent: Paragraph 0070; 0071; 0083; 0084
[2] Patent: WO2014/8295, 2014, A1. Location in patent: Paragraph 0254-0262
[3] Patent: CN105399694, 2016, A. Location in patent: Paragraph 0085; 0086; 0087; 0088
[4] Patent: CN107098866, 2017, A. Location in patent: Paragraph 0079; 0080; 0081; 0082; 0083
lesinurad intSupplier
- Tel
- sales@boylechem.com
- Tel
- 0757-86329057 18934348241
- sales4.gd@hwrkchemical.com
- Tel
- 400-6009262 16621234537
- chenyj@titansci.com
- Tel
- 025-58741518 13327700685
- sales@vcarepharmatech.com
- Tel
- 021-58955608,2250286 15921236618
- blinkzeng@gmail.com
lesinurad int(1533519-85-5)Related Product Information
- Lesinurad Impurity 10
- Lesinurad Impurity 4
- 1-cyclopropylnaphthalene
- Lesinurad Impurity J
- NAPHTHALENE, 1-CYCLOPROPYL-4-ISOTHIOCYANATO-
- RDEA 594
- 4-(4-cyclopropylnaphthalen-1-yl)-1H-1,2,4-triazole-5(4H)-thione
- Lesinurad Impurity 29
- Lesinurad Impurity 23
- Lesinurad Impurity 5 Sodium Salt
- 3-bromo-4-(4-cyclopropylnaphthalen-1-yl)-1H-1,2,4-triazole-5(4H)-thione
- N-(4-Cyclopropyl-1-naphthalenyl)-2-formylhydrazinecarbothioamide
- Lesinurad Impurity 38
- Lesinurad Impurity 32 (Mixture of Isomers)
- Lesinurad Impurity H
- Lesinurad Impurity 24
- Lesinurad Impurity N
- Lesinurad Impurity 27